Takeda Pharmaceutical Co (TSE:4502) Accounts Payable : 円483,666 Mil (As of Dec. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Takeda Pharmaceutical Co Accounts Payable?

Takeda Pharmaceutical Co's Accounts Payable for the quarter that ended in Dec. 2023 was 円483,666 Mil.

Takeda Pharmaceutical Co's quarterly Accounts Payable declined from Jun. 2023 (円440,924 Mil) to Sep. 2023 (円421,078 Mil) but then increased from Sep. 2023 (円421,078 Mil) to Dec. 2023 (円483,666 Mil).

Takeda Pharmaceutical Co's annual Accounts Payable increased from Mar. 2021 (円232,105 Mil) to Mar. 2022 (円295,934 Mil) and increased from Mar. 2022 (円295,934 Mil) to Mar. 2023 (円307,453 Mil).

Takeda Pharmaceutical Co Accounts Payable Historical Data

The historical data trend for Takeda Pharmaceutical Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Accounts Payable Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable

Get a 7-Day Free Trial

212,348.00

211,627.00

232,105.00

295,934.00

307,453.00

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable	Get a 7-Day Free Trial															381,109.00	307,453.00	440,924.00	421,078.00	483,666.00

Takeda Pharmaceutical Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Takeda Pharmaceutical Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (TSE:4502) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (TSE:4502) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA TAK:Mexico TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (TSE:4502) Headlines

No Headlines